Sunflower Pharmaceutical Group Co.,Ltd (SHE:002737)
China · Delayed Price · Currency is CNY 14.02
+0.04 (0.29%)
Feb 3, 2026, 3:04 PM CST
SHE:002737 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | -128.33 | 492.05 | 1,119 | 867.22 | 704.74 | 584.45 |
Depreciation & Amortization | 178.98 | 178.98 | 181.2 | 268.81 | 167.77 | 149.15 |
Other Amortization | 5.67 | 5.67 | 2.05 | 1.77 | 2.17 | 1.64 |
Loss (Gain) From Sale of Assets | 0.24 | 0.24 | -3.23 | -7.43 | -47.77 | 5.41 |
Asset Writedown & Restructuring Costs | 25.79 | 25.79 | 0.48 | 26.43 | 29.68 | 38.34 |
Loss (Gain) From Sale of Investments | -11.95 | -11.95 | -30.58 | 9.92 | -26.36 | -14.23 |
Provision & Write-off of Bad Debts | 7.63 | 7.63 | -4.6 | 1.06 | 27.05 | -6.56 |
Other Operating Activities | 1,287 | 47.6 | 54.88 | 39.18 | 52.53 | 44.18 |
Change in Accounts Receivable | -415.02 | -415.02 | 77.04 | 26.33 | 38.45 | 332.38 |
Change in Inventory | -25.49 | -25.49 | -241.47 | 73.5 | -152.67 | 101.66 |
Change in Accounts Payable | -634.38 | -634.38 | -286.2 | 662.12 | 57.9 | -82.14 |
Change in Other Net Operating Assets | 2.77 | 2.77 | 25.66 | 15.16 | 10.43 | - |
Operating Cash Flow | 312.02 | -307.48 | 889.69 | 1,975 | 865.23 | 1,170 |
Operating Cash Flow Growth | 202.95% | - | -54.96% | 128.30% | -26.04% | 19.21% |
Capital Expenditures | -82.74 | -92.79 | -149.16 | -152.9 | -118.31 | -212.73 |
Sale of Property, Plant & Equipment | -0.59 | 0.33 | 4.05 | 3.98 | 0.69 | 97.06 |
Cash Acquisitions | - | - | - | - | -1.1 | - |
Investment in Securities | -480.36 | 60.53 | 147.7 | -517.45 | -790.76 | -98.39 |
Other Investing Activities | 34.51 | 34.47 | 33.61 | 21.94 | 19.76 | 10.21 |
Investing Cash Flow | -529.18 | 2.54 | 36.2 | -644.43 | -889.72 | -203.85 |
Short-Term Debt Issued | - | 0.02 | 14.43 | - | - | - |
Long-Term Debt Issued | - | - | - | 420 | 306.58 | 350.52 |
Total Debt Issued | 18.02 | 0.02 | 14.43 | 420 | 306.58 | 350.52 |
Long-Term Debt Repaid | - | -16.7 | -426.47 | -238.12 | -383.49 | -466.38 |
Total Debt Repaid | -6.7 | -16.7 | -426.47 | -238.12 | -383.49 | -466.38 |
Net Debt Issued (Repaid) | 11.32 | -16.68 | -412.04 | 181.88 | -76.91 | -115.86 |
Issuance of Common Stock | - | - | - | 22.13 | 28.01 | - |
Repurchase of Common Stock | - | - | - | - | - | -83.57 |
Common Dividends Paid | -292.06 | -885.2 | -588.51 | -416.7 | -212.19 | -594.01 |
Other Financing Activities | -14.98 | -40.63 | -38.28 | -33.87 | -48.24 | 9.84 |
Financing Cash Flow | -295.71 | -942.51 | -1,039 | -246.57 | -309.33 | -783.6 |
Foreign Exchange Rate Adjustments | 0.31 | -0.3 | 0.23 | -0.02 | - | - |
Net Cash Flow | -512.57 | -1,248 | -112.71 | 1,084 | -333.82 | 182.42 |
Free Cash Flow | 229.28 | -400.27 | 740.52 | 1,822 | 746.92 | 957.14 |
Free Cash Flow Growth | - | - | -59.37% | 144.00% | -21.96% | 57.66% |
Free Cash Flow Margin | 10.95% | -11.85% | 12.99% | 35.77% | 16.74% | 27.65% |
Free Cash Flow Per Share | 0.41 | -0.68 | 1.27 | 3.11 | 1.28 | 1.64 |
Cash Income Tax Paid | 208.37 | 459.29 | 723.41 | 579.81 | 565.31 | 436.69 |
Levered Free Cash Flow | 295.96 | -504.18 | 349.11 | 1,537 | 698.11 | 530.97 |
Unlevered Free Cash Flow | 297.94 | -501.96 | 352.84 | 1,543 | 704.48 | 535.59 |
Change in Working Capital | -1,053 | -1,053 | -429.66 | 768.39 | -44.59 | 367.47 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.